Sandra Leung - EVP, General Counsel at Bristol Myers Squibb Co

Insider Transactions and Holdings

Entity Type
Individual
Role
EVP, General Counsel
Stock Symbol
BMY, CELG-RI on NYSE, BMYMP on OTC
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Sandra Leung since 12/4/2024

Holdings reported by Sandra Leung for Bristol Myers Squibb Co

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock, $0.10 par value 364K $23M $63.11 Mar 10, 2025 Direct
Common Stock, $0.10 par value 347K $18.7M $53.79 Mar 10, 2024 Direct
Common Stock, $0.10 par value 93.4K $5.9M $63.11 Mar 10, 2025 Trust (SLAT)
Common Stock, $0.10 par value 93.4K $5.03M $53.79 Mar 10, 2024 Trust (SLAT)
Market Share Units 24.8K $1.31M $52.99 Mar 10, 2025 Direct Common Stock, $0.10 par value
Common Stock, $0.10 par value 7.64K $482K $63.11 Mar 10, 2025 BMS Savings and Investment Program
Common Stock, $0.10 par value 7.29K $392K $53.79 Mar 10, 2024 BMS Savings and Investment Program
Performance Shares 37.2K Mar 10, 2025 Direct Common Stock, $0.10 par value

Transactions reported by Sandra Leung for Bristol Myers Squibb Co

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.